ATE462418T1 - Stabile pharmazeutische zubereitungen zur kontrollierten freisetzung von fenofibrat and pravastatin - Google Patents
Stabile pharmazeutische zubereitungen zur kontrollierten freisetzung von fenofibrat and pravastatinInfo
- Publication number
- ATE462418T1 ATE462418T1 AT03817894T AT03817894T ATE462418T1 AT E462418 T1 ATE462418 T1 AT E462418T1 AT 03817894 T AT03817894 T AT 03817894T AT 03817894 T AT03817894 T AT 03817894T AT E462418 T1 ATE462418 T1 AT E462418T1
- Authority
- AT
- Austria
- Prior art keywords
- pravastatin
- fenofibrate
- controlled release
- pharmaceutical preparations
- stable pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/BE2003/000133 WO2005013940A1 (en) | 2003-08-06 | 2003-08-06 | Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE462418T1 true ATE462418T1 (de) | 2010-04-15 |
Family
ID=34120383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03817894T ATE462418T1 (de) | 2003-08-06 | 2003-08-06 | Stabile pharmazeutische zubereitungen zur kontrollierten freisetzung von fenofibrat and pravastatin |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1651194B1 (de) |
AT (1) | ATE462418T1 (de) |
CA (1) | CA2534910C (de) |
DE (1) | DE60331963D1 (de) |
DK (1) | DK1651194T3 (de) |
ES (1) | ES2342885T3 (de) |
SI (1) | SI1651194T1 (de) |
WO (1) | WO2005013940A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
WO2006008757A2 (en) * | 2004-05-05 | 2006-01-26 | Cadila Healthcare Limited | Stabilized pharmaceutical compositions of pravastatin |
JP2008509154A (ja) | 2004-08-06 | 2008-03-27 | トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド | 新規なスタチン薬剤組成物および関連治療方法 |
EP1818050A1 (de) * | 2006-02-10 | 2007-08-15 | Stada Arzneimittel Ag | Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor |
EP1825848A3 (de) * | 2006-02-10 | 2010-03-03 | Stada Arzneimittel Ag | Stabile pharmazeutische Zusammensetzungen umfassend einen HMG-CoA-Reduktase Inhibitor |
JP5628480B2 (ja) * | 2006-03-09 | 2014-11-19 | グラクソスミスクライン エルエルシー | 医薬成分を含有するコーティングカプセル |
US8784886B2 (en) | 2006-03-09 | 2014-07-22 | GlaxoSmithKline, LLC | Coating capsules with active pharmaceutical ingredients |
TR201005326A2 (tr) * | 2010-06-30 | 2012-01-23 | Bi̇lgi̇ç Mahmut | Çoklu dozaj formları. |
CN109307720B (zh) * | 2018-10-19 | 2021-08-10 | 深圳天辰医疗科技有限公司 | 一种组合物和复合校准品及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6368620B2 (en) * | 1999-06-11 | 2002-04-09 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
PL202778B1 (pl) * | 2001-02-22 | 2009-07-31 | Skyepharma Canada Inc | Postać dawkowana kombinacji statyny i fenofibratu, sposób jej wytwarzania i zastosowanie |
HUP0401234A2 (hu) * | 2001-03-27 | 2004-11-29 | Ranbaxy Laboratories Limited | Pravastatin stabil gyógyászati kompozíciója és eljárás az előállítására |
WO2003013607A1 (en) * | 2001-08-07 | 2003-02-20 | Galephar M/F | ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR |
WO2003013608A1 (en) * | 2001-08-07 | 2003-02-20 | Galephar M/F | ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINAITION OF PPARα AND A HMG-COA REDUCTASE INHIBITOR |
US6576256B2 (en) * | 2001-08-28 | 2003-06-10 | The Brigham And Women's Hospital, Inc. | Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
-
2003
- 2003-08-06 SI SI200331811T patent/SI1651194T1/sl unknown
- 2003-08-06 DK DK03817894.3T patent/DK1651194T3/da active
- 2003-08-06 WO PCT/BE2003/000133 patent/WO2005013940A1/en active Application Filing
- 2003-08-06 ES ES03817894T patent/ES2342885T3/es not_active Expired - Lifetime
- 2003-08-06 DE DE60331963T patent/DE60331963D1/de not_active Expired - Lifetime
- 2003-08-06 CA CA2534910A patent/CA2534910C/en not_active Expired - Lifetime
- 2003-08-06 EP EP03817894A patent/EP1651194B1/de not_active Expired - Lifetime
- 2003-08-06 AT AT03817894T patent/ATE462418T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2003254428A1 (en) | 2005-02-25 |
CA2534910A1 (en) | 2005-02-17 |
DK1651194T3 (da) | 2010-07-26 |
ES2342885T3 (es) | 2010-07-16 |
DE60331963D1 (de) | 2010-05-12 |
SI1651194T1 (sl) | 2010-08-31 |
EP1651194B1 (de) | 2010-03-31 |
EP1651194A1 (de) | 2006-05-03 |
CA2534910C (en) | 2011-11-15 |
WO2005013940A1 (en) | 2005-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2004001556A (es) | Preparaciones acidas de insulina con establidad mejorada | |
IS6344A (is) | Lyfjasamsetningar sem leiða til aukinna lyfjastyrkja | |
ATE357216T1 (de) | Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen | |
DE69720787D1 (de) | Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure | |
HUP0303817A2 (hu) | Közepes lánchosszúságú zsírsavak, gliceridek és analógok, mint neutrofil túlélési és aktivitási faktorok és ezeket tartalmazó gyógyszerkészítmények | |
ATE260647T1 (de) | Mechanisch stabile pharmazeutische darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive substanzen | |
BR0112073A (pt) | Combinações terapêuticas de ácidos graxos | |
ATE317280T1 (de) | Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung | |
WO2003028757A1 (fr) | Nouvelle methode pour induire des lymphocytes t specifiques d'antigenes | |
ATE311201T1 (de) | Testosteron-ester formulierung zur anwendung am menschen | |
ATE462418T1 (de) | Stabile pharmazeutische zubereitungen zur kontrollierten freisetzung von fenofibrat and pravastatin | |
NO20073457L (no) | Stabile sammensetninger av fenofibrat med fettsyreestere | |
UA10208A (uk) | Дерматологічний косметичний засіб | |
JP2002536304A5 (de) | ||
DE59906362D1 (de) | Verwendung von lipopeptiden oder lipoproteinen zur wundbehandlung | |
JPS6468316A (en) | External plaster containing salbutamol | |
EA200501223A1 (ru) | Терапевтическая система, содержащая амоксициллин и клавулановую кислоту | |
DK1414496T3 (da) | Farmaceutisk sammensætning indeholdende en kombination af PPAR-alpha, pravastatin og mindst en polyglycoliseret glycerid | |
DE69927260D1 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
ATE199495T1 (de) | Pharmazeutische zubereitung zur direktverpressung | |
DE69706241D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung der Leukämie enthaltend 9-cis-Retinoinsäure-alpha-Tocopherolester | |
WO2008155920A1 (ja) | 肝細胞増殖促進作用を有する医薬 | |
CA2427289A1 (en) | Fat composition and hexacosanoic acid depressant for oral or enteral administration | |
DE69318166D1 (de) | Mit morphogen angereicherte nahrungszusammenstellung | |
RU95105084A (ru) | Гепатопротекторное средство природного происхождения |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |